|
|
|
 |
|
| Trends in Five-Year Relative Cancer Survival Rates* (%) by Race and Year of Diagnosis, US, 1974-1996 |
 |
|
TABLE 12
CA Cancer J Clin 2001;51:35
|
|
1974-76 |
1980-82 |
1989-96 |
1974-76 |
|
1980-82 |
|
1989-96 |
1974-76 |
1980-82 |
1989-96 |
| SITE |
|
|
|
White |
|
|
|
|
|
|
|
|
|
Black |
|
|
|
|
|
|
|
|
All Races |
|
| All Sites |
|
51 |
|
52 |
|
62 |
|
† |
|
39 |
|
|
|
40 |
|
|
49 |
† |
|
50 |
|
51 |
|
60 |
† |
| Brain |
|
22 |
|
25 |
|
30 |
|
† |
|
27 |
|
|
|
31 |
|
|
38 |
† |
|
23 |
|
25 |
|
31 |
† |
| Breast (Female) |
|
75 |
|
77 |
|
86 |
|
† |
|
63 |
|
|
|
66 |
|
|
71 |
† |
|
75 |
|
76 |
|
85 |
† |
| Uterine Cervix |
|
70 |
|
68 |
|
72 |
|
† |
|
64 |
|
|
|
61 |
|
|
59 |
|
|
69 |
|
67 |
|
70 |
| Colon |
|
51 |
|
56 |
|
63 |
|
† |
|
46 |
|
|
|
49 |
|
|
52 |
† |
|
51 |
|
55 |
|
62 |
† |
|
| Uterine Corpus |
|
89 |
|
83 |
|
86 |
|
† |
|
61 |
|
|
|
55 |
|
|
57 |
|
|
88 |
|
82 |
|
84 |
† |
| Esophagus |
|
|
5 |
|
|
8 |
|
13 |
|
† |
|
|
4 |
|
|
|
|
5 |
|
|
|
9 |
† |
|
|
5 |
|
|
7 |
|
12 |
† |
| Hodgkin's Disease |
|
72 |
|
75 |
|
83 |
|
† |
|
69 |
|
|
|
72 |
|
|
77 |
|
|
71 |
|
75 |
|
82 |
† |
| Kidney |
|
52 |
|
51 |
|
62 |
|
† |
|
49 |
|
|
|
56 |
|
|
58 |
† |
|
52 |
|
52 |
|
61 |
† |
|
| Larynx |
|
67 |
|
69 |
|
66 |
|
|
|
59 |
|
|
|
58 |
|
|
54 |
|
|
66 |
|
68 |
|
65 |
|
| Leukemia |
|
35 |
|
40 |
|
45 |
|
† |
|
32 |
|
|
|
33 |
|
|
34 |
|
|
35 |
|
39 |
|
44 |
† |
| Liver |
|
|
5 |
|
|
4 |
|
|
6 |
|
† |
|
|
2 |
|
|
|
|
2 |
|
|
|
3 |
|
|
|
4 |
|
|
4 |
|
|
5 |
† |
| Lung & Bronchus |
|
13 |
|
14 |
|
14 |
|
† |
|
12 |
|
|
|
12 |
|
|
11 |
|
|
12 |
|
13 |
|
14 |
† |
|
| Melanoma |
|
80 |
|
83 |
|
89 |
|
† |
|
67 |
‡ |
|
|
61 |
§ |
|
70 |
‡ |
|
80 |
|
83 |
|
88 |
† |
| Multiple Myeloma |
|
24 |
|
28 |
|
28 |
|
† |
|
28 |
|
|
|
30 |
|
|
31 |
|
|
25 |
|
28 |
|
29 |
† |
| Non-Hodgkin's Lymphoma |
|
48 |
|
52 |
|
53 |
|
† |
|
49 |
|
|
50 |
|
|
42 |
† |
|
47 |
|
51 |
|
52 |
† |
| Oral Cavity |
|
55 |
|
56 |
|
56 |
|
|
|
36 |
|
|
|
31 |
|
|
35 |
|
|
54 |
|
53 |
|
54 |
|
| Ovary |
|
37 |
|
39 |
|
50 |
|
† |
|
41 |
|
|
|
38 |
|
|
48 |
† |
|
37 |
|
39 |
|
50 |
† |
| Pancreas |
|
|
3 |
|
|
3 |
|
|
4 |
|
† |
|
|
3 |
|
|
|
|
5 |
|
|
|
4 |
† |
|
|
3 |
|
|
3 |
|
|
4 |
† |
| Prostate |
|
68 |
|
75 |
|
94 |
|
† |
|
59 |
|
|
|
65 |
|
|
87 |
† |
|
67 |
|
73 |
|
93 |
† |
| Rectum |
|
49 |
|
53 |
|
61 |
|
† |
|
42 |
|
|
|
38 |
|
|
52 |
† |
|
49 |
|
52 |
|
60 |
† |
|
| Stomach |
|
15 |
|
16 |
|
20 |
|
† |
|
17 |
|
|
|
19 |
|
|
22 |
|
|
15 |
|
18 |
|
21 |
† |
| Testis |
|
79 |
|
92 |
|
96 |
|
† |
|
76 |
‡ |
|
|
90 |
‡ |
|
88 |
|
|
79 |
|
92 |
|
95 |
† |
| Thyroid |
|
92 |
|
94 |
|
96 |
|
† |
|
88 |
|
|
|
95 |
|
|
91 |
|
|
92 |
|
95 |
|
95 |
† |
| Urinary Bladder |
|
74 |
|
79 |
|
82 |
|
† |
|
48 |
|
|
|
59 |
|
|
64 |
† |
|
73 |
|
78 |
|
81 |
† |
|
|
*Survival rates are adjusted for normal life expectancy and are based on cases diagnosed from 1989 to 1996, followed through 1997. †The difference in rates between 1974-76 and 1989-96 is statistically significant (p < 0.05). ‡The standard error of the survival rate is between 5 and 10 percentage points. §The standard error of the survival rate is greater than 10 percentage points. Data Source: Surveillance, Epidemiology and End Results Program 1973-1997, Division of Cancer Control and Population Sciences, National Cancer Insititute, 2000.
|
|
 |
|
 |